Literature DB >> 12363286

Calcium regulation and muscle disease.

I M P Gommans1, M H M Vlak, A de Haan, B G M van Engelen.   

Abstract

Changes in intracellular Ca2+-concentration play an important role in the excitation-contraction-relaxation cycle of skeletal muscle. In this review we describe various inheritable muscle diseases to highlight the role of Ca2+-regulatory mechanisms. Upon excitation the ryanodine receptor releases Ca2+ in the cytosol. During and after contraction the sarcoplasmic reticulum (SR) Ca2+ATPase (SERCA) pumps Ca2+ back in the SR resulting in relaxation. An abnormal change in the intracellular Ca2+-concentration results in defective muscle contraction and/or relaxation, which is the cause of various muscle diseases. Malignant hyperthermia (MH) and central core disease (CCD) are both caused by mutations in the ryanodine receptor but show different clinical phenotypes. In MH an acute increase of Ca2+ results in excessive muscle contraction causing rigidity, while in CCD a chronic rise of cytosolic Ca2+ is seen, leading to mitochondrial damage, disorganization of myofibrils and muscle weakness. In Brody disease and also in mitochondrial myopathies, SERCA functions sub optimal causing a prolonged physiological Ca2+-elevation leading to slowing of relaxation. Defective actin-myosin interactions, as in nemaline myopathy and also in mitochondrial myopathies due to ATP-shortage, cause Ca2+-hyposensitivity and slowness of contraction. Information of Ca2+-kinetics in these inherited muscular diseases improves our understanding of the role of calcium in the physiology and pathophysiology of the skeletal muscle cell.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12363286     DOI: 10.1023/a:1019984714528

Source DB:  PubMed          Journal:  J Muscle Res Cell Motil        ISSN: 0142-4319            Impact factor:   2.698


  24 in total

1.  A new phenotype of autosomal dominant nemaline myopathy.

Authors:  I M P Gommans; B G M van Engelen; H J ter Laak; H G Brunner; H Kremer; M Lammens; O J M Vogels
Journal:  Neuromuscul Disord       Date:  2002-01       Impact factor: 4.296

2.  Excitation--contraction uncoupling by a human central core disease mutation in the ryanodine receptor.

Authors:  G Avila; J J O'Brien; R T Dirksen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

3.  A new congenital non-progressive myopathy.

Authors:  K R MAGEE; G M SHY
Journal:  Brain       Date:  1956-12       Impact factor: 13.501

4.  A mutation in alpha-tropomyosin(slow) affects muscle strength, maturation and hypertrophy in a mouse model for nemaline myopathy.

Authors:  M A Corbett; C S Robinson; G F Dunglison; N Yang; J E Joya; A W Stewart; C Schnell; P W Gunning; K N North; E C Hardeman
Journal:  Hum Mol Genet       Date:  2001-02-15       Impact factor: 6.150

5.  A mutation in the transmembrane/luminal domain of the ryanodine receptor is associated with abnormal Ca2+ release channel function and severe central core disease.

Authors:  P J Lynch; J Tong; M Lehane; A Mallet; L Giblin; J J Heffron; P Vaughan; G Zafra; D H MacLennan; T V McCarthy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

6.  Muscle function in a patient with Brody's disease.

Authors:  C J De Ruiter; R A Wevers; B G Van Engelen; P W Verdijk; A De Haan
Journal:  Muscle Nerve       Date:  1999-06       Impact factor: 3.217

Review 7.  Physiological consequences of tropomyosin mutations associated with cardiac and skeletal myopathies.

Authors:  D E Michele; J M Metzger
Journal:  J Mol Med (Berl)       Date:  2000       Impact factor: 4.599

Review 8.  Ca2+ signalling and muscle disease.

Authors:  D H MacLennan
Journal:  Eur J Biochem       Date:  2000-09

9.  Mutations in the gene-encoding SERCA1, the fast-twitch skeletal muscle sarcoplasmic reticulum Ca2+ ATPase, are associated with Brody disease.

Authors:  A Odermatt; P E Taschner; V K Khanna; H F Busch; G Karpati; C K Jablecki; M H Breuning; D H MacLennan
Journal:  Nat Genet       Date:  1996-10       Impact factor: 38.330

10.  Ca2+-ATPase deficiency in a patient with an exertional muscle pain syndrome.

Authors:  D J Taylor; M J Brosnan; D L Arnold; P J Bore; P Styles; J Walton; G K Radda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-11       Impact factor: 10.154

View more
  12 in total

1.  Time-resolved charge translocation by sarcoplasmic reticulum Ca-ATPase measured on a solid supported membrane.

Authors:  Francesco Tadini Buoninsegni; Gianluca Bartolommei; Maria Rosa Moncelli; Giuseppe Inesi; Rolando Guidelli
Journal:  Biophys J       Date:  2004-06       Impact factor: 4.033

Review 2.  Novel sarco(endo)plasmic reticulum proteins and calcium homeostasis in striated muscles.

Authors:  A Divet; S Paesante; C Bleunven; A Anderson; S Treves; F Zorzato
Journal:  J Muscle Res Cell Motil       Date:  2005-10-14       Impact factor: 2.698

Review 3.  Stressed out: the skeletal muscle ryanodine receptor as a target of stress.

Authors:  Andrew M Bellinger; Marco Mongillo; Andrew R Marks
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

4.  Analysis of conditional paralytic mutants in Drosophila sarco-endoplasmic reticulum calcium ATPase reveals novel mechanisms for regulating membrane excitability.

Authors:  S Sanyal; C Consoulas; H Kuromi; A Basole; L Mukai; Y Kidokoro; K S Krishnan; M Ramaswami
Journal:  Genetics       Date:  2004-11-01       Impact factor: 4.562

5.  Myopathy in Gaucher disease.

Authors:  Li-Kai Tsai; Yin-Hsiu Chien; Chih-Chao Yang; Wuh-Liang Hwu
Journal:  J Inherit Metab Dis       Date:  2008-01-16       Impact factor: 4.982

6.  Systemic ablation of RyR3 alters Ca2+ spark signaling in adult skeletal muscle.

Authors:  Noah Weisleder; Christopher Ferrante; Yutaka Hirata; Claude Collet; Yi Chu; Heping Cheng; Hiroshi Takeshima; Jianjie Ma
Journal:  Cell Calcium       Date:  2007-04-06       Impact factor: 6.817

7.  Efavirenz, atazanavir, and ritonavir disrupt sarcoplasmic reticulum Ca2+ homeostasis in skeletal muscles.

Authors:  Fadhel A Alomar; Chengju Tian; Prasanta K Dash; JoEllyn M McMillan; Howard E Gendelman; Santhi Gorantla; Keshore R Bidasee
Journal:  Antiviral Res       Date:  2021-01-13       Impact factor: 5.970

8.  Inhibition of sarcoplasmic Ca2+-ATPase increases caffeine- and halothane-induced contractures in muscle bundles of malignant hyperthermia susceptible and healthy individuals.

Authors:  Frank Schuster; Rainer Müller; Edmund Hartung; Norbert Roewer; Martin Anetseder
Journal:  BMC Anesthesiol       Date:  2005-06-09       Impact factor: 2.217

9.  Successful use of albuterol in a patient with central core disease and mitochondrial dysfunction.

Authors:  L T W Schreuder; M W G Nijhuis-van der Sanden; A de Hair; G Peters; S Wortmann; L A Bok; E Morava
Journal:  J Inherit Metab Dis       Date:  2010-05-05       Impact factor: 4.982

10.  Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy.

Authors:  James J Dowling; Andrew P Vreede; Sean E Low; Elizabeth M Gibbs; John Y Kuwada; Carsten G Bonnemann; Eva L Feldman
Journal:  PLoS Genet       Date:  2009-02-06       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.